Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Increased degradation of ATP is driven by memory regulatory T cells in kidney transplantation tolerance.

Durand M, Dubois F, Dejou C, Durand E, Danger R, Chesneau M, Brosseau C, Guerif P, Soulillou JP, Degauque N, Eliaou JF, Giral M, Bonnefoy N, Brouard S.

Kidney Int. 2018 May;93(5):1154-1164. doi: 10.1016/j.kint.2017.12.004. Epub 2018 Feb 15.

PMID:
29455908
2.

The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway.

Laprevotte E, Cochaud S, du Manoir S, Lapierre M, Dejou C, Philippe M, Giustiniani J, Frewer KA, Sanders AJ, Jiang WG, Michaud HA, Colombo PE, Bensussan A, Alberici G, Bastid J, Eliaou JF, Bonnefoy N.

Oncotarget. 2017 Dec 6;8(69):113360-113372. doi: 10.18632/oncotarget.23008. eCollection 2017 Dec 26.

3.

IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population.

Barjon C, Michaud HA, Fages A, Dejou C, Zampieri A, They L, Gennetier A, Sanchez F, Gros L, Eliaou JF, Bonnefoy N, Lafont V.

Oncoimmunology. 2017 Oct 4;7(1):e1379642. doi: 10.1080/2162402X.2017.1379642. eCollection 2017.

4.

PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody.

They L, Michaud HA, Becquart O, Lafont V, Guillot B, Boissière-Michot F, Jarlier M, Mollevi C, Eliaou JF, Bonnefoy N, Gros L.

Oncoimmunology. 2017 Jul 20;6(10):e1353857. doi: 10.1080/2162402X.2017.1353857. eCollection 2017.

5.

Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI).

Rettman P, Malard F, Legrand N, Avinens O, Eliaou JF, Picard C, Dormoy A, Lafarge X, de Matteis M, Kennel A, Loiseau P, Devys A, Boudifa A, Absi L, Fort M, Masson D, Quainon F, Theodorou I, Batho A, Parissiadis A, Delbos F, Drouet M, Senitzer D, Marry E, Raus N, Yakoub-Agha I, Cesbron A, Retière C, Gagne K.

Bone Marrow Transplant. 2016 Nov;51(11):1499-1503. doi: 10.1038/bmt.2016.151. Epub 2016 Jun 6. No abstract available.

PMID:
27272444
6.

Effects of alcohol withdrawal on monocyte subset defects in chronic alcohol users.

Donnadieu-Rigole H, Mura T, Portales P, Duroux-Richard I, Bouthier M, Eliaou JF, Perney P, Apparailly F.

J Leukoc Biol. 2016 Nov;100(5):1191-1199. Epub 2016 Jun 2.

PMID:
27256567
7.

Association of HLA-A and Non-Classical HLA Class I Alleles.

Carlini F, Ferreira V, Buhler S, Tous A, Eliaou JF, René C, Chiaroni J, Picard C, Di Cristofaro J.

PLoS One. 2016 Oct 4;11(10):e0163570. doi: 10.1371/journal.pone.0163570. eCollection 2016.

8.

Corrigendum to "One of the Immune Activation Profiles Observed in HIV-1-Infected Adults with Suppressed Viremia is Linked to Metabolic Syndrome: The ACTIVIH Study" [EBioMedicine 8 (2016) 265-276].

Psomas C, Younas M, Reynes C, Cezar R, Portalès P, Tuaillon E, Guigues A, Merle C, Atoui N, Fernandez C, Le Moing V, Barbuat C, Marin G, Nagot N, Sotto A, Eliaou JF, Sabatier R, Reynes J, Corbeau P.

EBioMedicine. 2016 Aug;10:318-322. doi: 10.1016/j.ebiom.2016.08.003. Epub 2016 Aug 4. No abstract available.

9.

One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study.

Psomas C, Younas M, Reynes C, Cezar R, Portalès P, Tuaillon E, Guigues A, Merle C, Atoui N, Fernandez C, Le Moing V, Barbuat C, Marin G, Nagot N, Sotto A, Eliaou JF, Sabatier R, Reynes J, Corbeau P.

EBioMedicine. 2016 Jun;8:265-276. doi: 10.1016/j.ebiom.2016.05.008. Epub 2016 May 10.

10.

Expression of classical HLA class I molecules: regulation and clinical impacts: Julia Bodmer Award Review 2015.

René C, Lozano C, Eliaou JF.

HLA. 2016 May;87(5):338-49. doi: 10.1111/tan.12787. Epub 2016 Apr 6. Review.

PMID:
27060357
11.

Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity.

Tafti M, Lammers GJ, Dauvilliers Y, Overeem S, Mayer G, Nowak J, Pfister C, Dubois V, Eliaou JF, Eberhard HP, Liblau R, Wierzbicka A, Geisler P, Bassetti CL, Mathis J, Lecendreux M, Khatami R, Heinzer R, Haba-Rubio J, Feketeova E, Baumann CR, Kutalik Z, Tiercy JM.

Sleep. 2016 Mar 1;39(3):581-7. doi: 10.5665/sleep.5532.

12.

5' and 3' untranslated regions contribute to the differential expression of specific HLA-A alleles.

René C, Lozano C, Villalba M, Eliaou JF.

Eur J Immunol. 2015 Dec;45(12):3454-63. doi: 10.1002/eji.201545927. Epub 2015 Oct 13.

13.

CD39: A complementary target to immune checkpoints to counteract tumor-mediated immunosuppression.

Bonnefoy N, Bastid J, Alberici G, Bensussan A, Eliaou JF.

Oncoimmunology. 2015 Feb 3;4(5):e1003015. eCollection 2015 May.

14.

IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells.

Mombelli S, Cochaud S, Merrouche Y, Garbar C, Antonicelli F, Laprevotte E, Alberici G, Bonnefoy N, Eliaou JF, Bastid J, Bensussan A, Giustiniani J.

Sci Rep. 2015 Jul 8;5:11874. doi: 10.1038/srep11874.

15.

Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity.

Michaud HA, Eliaou JF, Lafont V, Bonnefoy N, Gros L.

Oncoimmunology. 2014 Dec 13;3(9):e955684. eCollection 2014 Oct. Review.

16.

Emerging clinical phenotypes associated with anti-cytokine autoantibodies.

Vincent T, Plawecki M, Goulabchand R, Guilpain P, Eliaou JF.

Autoimmun Rev. 2015 Jun;14(6):528-35. doi: 10.1016/j.autrev.2015.01.015. Epub 2015 Jan 26. Review.

PMID:
25633324
17.

Plasticity of γδ T Cells: Impact on the Anti-Tumor Response.

Lafont V, Sanchez F, Laprevotte E, Michaud HA, Gros L, Eliaou JF, Bonnefoy N.

Front Immunol. 2014 Dec 8;5:622. doi: 10.3389/fimmu.2014.00622. eCollection 2014. Review.

18.

Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react.

Pochon C, Oger E, Michel G, Dalle JH, Salmon A, Nelken B, Bertrand Y, Cavé H, Cayuela JM, Grardel N, Macintyre E, Margueritte G, Méchinaud F, Rohrlich P, Paillard C, Demeocq F, Schneider P, Plantaz D, Poirée M, Eliaou JF, Semana G, Drunat S, Jonveaux P, Bordigoni P, Gandemer V.

Br J Haematol. 2015 Apr;169(2):249-61. doi: 10.1111/bjh.13272. Epub 2014 Dec 19.

PMID:
25522886
19.

Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.

Bastid J, Regairaz A, Bonnefoy N, Déjou C, Giustiniani J, Laheurte C, Cochaud S, Laprevotte E, Funck-Brentano E, Hemon P, Gros L, Bec N, Larroque C, Alberici G, Bensussan A, Eliaou JF.

Cancer Immunol Res. 2015 Mar;3(3):254-65. doi: 10.1158/2326-6066.CIR-14-0018. Epub 2014 Nov 17.

20.

Is there any impact of HLA-DPB1 disparity in 10/10 HLA-matched unrelated hematopoietic SCT? Results of a French multicentric retrospective study.

Gagne K, Loiseau P, Dubois V, Dufossé F, Perrier P, Dormoy A, Jollet I, Renac V, Masson D, Picard C, Lafarge X, Hanau D, Quainon F, Delbos F, Coeffic B, Absi L, Eliaou JF, Moalic V, Fort M, de Matteis M, Theodorou I, Hau F, Batho A, Pedron B, Caillat-Zucman S, Marry E, Raus N, Yakoub-Agha I, Cesbron A.

Bone Marrow Transplant. 2015 Feb;50(2):232-6. doi: 10.1038/bmt.2014.253. Epub 2014 Nov 3.

PMID:
25365066
21.

Lymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis.

Bastid J, Bonnefoy N, Eliaou JF, Bensussan A.

Oncoimmunology. 2014 Mar 27;3:e28273. eCollection 2014.

22.

[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (Part 1)].

Blaise D, Nguyen S, Bay JO, Chevallier P, Contentin N, Dhédin N, Duléry R, Eliaou JF, Rubio MT, Suarez F, Bulabois CE, Cornillon J, Huynh A, Magro L, Michallet M, Paillard C, Turlure P, Yakoub-Agha I; SFGM-TC.

Pathol Biol (Paris). 2014 Aug;62(4):180-4. doi: 10.1016/j.patbio.2014.05.004. Epub 2014 Jun 25. French.

PMID:
24973859
23.

[Impact of anti-HLA antibodies on outcomes of allogeneic stem cell transplantation: a report by the SFGM-TC].

Loiseau P, Dubois V, Bonafoux B, Bulabois CE, Coiteux V, Eliaou JF, Labaky M, Michallet M, Renac V, Delbos F, Kennel A, Detrait M, Devys A, Galambrun C, Yakoub-Agha I; SFGM-TC.

Pathol Biol (Paris). 2014 Aug;62(4):226-9. doi: 10.1016/j.patbio.2014.05.007. Epub 2014 Jun 25. French.

PMID:
24973858
24.

[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)].

Nguyen S, Blaise D, Bay JO, Chevallier P, Contentin N, Dhédin N, Duléry R, Eliaou JF, Rubio MT, Suarez F, Bulabois CE, Cornillon J, Huynh A, Magro L, Michallet M, Paillard C, Turlure P, Yakoub-Agha I; SFGM-TC.

Pathol Biol (Paris). 2014 Aug;62(4):185-9. doi: 10.1016/j.patbio.2014.05.002. Epub 2014 Jun 18. French.

PMID:
24954121
25.

The emerging role of Twist proteins in hematopoietic cells and hematological malignancies.

Merindol N, Riquet A, Szablewski V, Eliaou JF, Puisieux A, Bonnefoy N.

Blood Cancer J. 2014 Apr 25;4:e206. doi: 10.1038/bcj.2014.22. Review. Erratum in: Blood Cancer J. 2014 Oct;4:e254.

26.

Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.

Nerrant E, Salsac C, Charif M, Ayrignac X, Carra-Dalliere C, Castelnovo G, Goulabchand R, Tisseyre J, Raoul C, Eliaou JF, Labauge P, Vincent T.

Mult Scler. 2014 Nov;20(13):1699-703. doi: 10.1177/1352458514531086. Epub 2014 Apr 22.

PMID:
24756568
27.

Comprehensive characterization of immunoglobulin gene rearrangements in patients with chronic lymphocytic leukaemia.

René C, Prat N, Thuizat A, Broctawik M, Avinens O, Eliaou JF.

J Cell Mol Med. 2014 Jun;18(6):979-90. doi: 10.1111/jcmm.12215. Epub 2014 Apr 11.

28.

Impact of autoantibody glycosylation in autoimmune diseases.

Goulabchand R, Vincent T, Batteux F, Eliaou JF, Guilpain P.

Autoimmun Rev. 2014 Jul;13(7):742-50. doi: 10.1016/j.autrev.2014.02.005. Epub 2014 Mar 19. Review.

PMID:
24657512
29.

IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2.

Cochaud S, Giustiniani J, Thomas C, Laprevotte E, Garbar C, Savoye AM, Curé H, Mascaux C, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A, Bastid J.

Sci Rep. 2013 Dec 9;3:3456. doi: 10.1038/srep03456.

30.

Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.

Spierings E, Kim YH, Hendriks M, Borst E, Sergeant R, Canossi A, Oudshoorn M, Loiseau P, Dolstra H, Markiewicz M, Leffell MS, Pereira N, Kircher B, Turpeinen H, Eliaou JF, Gervais T, Laurin D, Enczmann J, Martinetti M, Thomson J, Oguz F, Santarone S, Partanen J, Siekiera U, Alessandrino EP, Kalayoglu S, Brand R, Goulmy E.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1244-53. doi: 10.1016/j.bbmt.2013.06.001. Epub 2013 Jun 10.

31.

Gender influences the birth order effect in HLA-identical stem cell transplantation.

Dierselhuis MP, Spierings E, Brand R, Hendriks M, Canossi A, Dolstra H, Eliaou JF, Enczmann J, Gervais T, Kircher B, Laurin D, Loiseau P, Sergeant R, Goulmy E.

Blood. 2013 Jun 6;121(23):4809-11. doi: 10.1182/blood-2013-02-485722. No abstract available.

32.

Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation.

Belot A, Kasher PR, Trotter EW, Foray AP, Debaud AL, Rice GI, Szynkiewicz M, Zabot MT, Rouvet I, Bhaskar SS, Daly SB, Dickerson JE, Mayer J, O'Sullivan J, Juillard L, Urquhart JE, Fawdar S, Marusiak AA, Stephenson N, Waszkowycz B, W Beresford M, Biesecker LG, C M Black G, René C, Eliaou JF, Fabien N, Ranchin B, Cochat P, Gaffney PM, Rozenberg F, Lebon P, Malcus C, Crow YJ, Brognard J, Bonnefoy N.

Arthritis Rheum. 2013 Aug;65(8):2161-71. doi: 10.1002/art.38008.

33.

16(th) IHIW: analysis of HLA population data, with updated results for 1996 to 2012 workshop data (AHPD project report).

Riccio ME, Buhler S, Nunes JM, Vangenot C, Cuénod M, Currat M, Di D, Andreani M, Boldyreva M, Chambers G, Chernova M, Chiaroni J, Darke C, Di Cristofaro J, Dubois V, Dunn P, Edinur HA, Elamin N, Eliaou JF, Grubic Z, Jaatinen T, Kanga U, Kervaire B, Kolesar L, Kunachiwa W, Lokki ML, Mehra N, Nicoloso G, Paakkanen R, Voniatis DP, Papasteriades C, Poli F, Richard L, Romón Alonso I, Slavčev A, Sulcebe G, Suslova T, Testi M, Tiercy JM, Varnavidou A, Vidan-Jeras B, Wennerström A, Sanchez-Mazas A.

Int J Immunogenet. 2013 Feb;40(1):21-30. doi: 10.1111/iji.12033. Epub 2012 Dec 22.

PMID:
23280239
34.

Immunological follow-up of patients with neuromyelitis optica: is there a good biomarker?

Chanson JB, de Seze J, Eliaou JF, Vincent T.

Lupus. 2013 Mar;22(3):229-32. doi: 10.1177/0961203312467669. Epub 2012 Nov 21. Review.

PMID:
23172901
35.

The intensity of immune activation is linked to the level of CCR5 expression in human immunodeficiency virus type 1-infected persons.

Portales P, Psomas KC, Tuaillon E, Mura T, Vendrell JP, Eliaou JF, Reynes J, Corbeau P.

Immunology. 2012 Sep;137(1):89-97. doi: 10.1111/j.1365-2567.2012.03609.x.

36.

ENTPD1/CD39 is a promising therapeutic target in oncology.

Bastid J, Cottalorda-Regairaz A, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A.

Oncogene. 2013 Apr 4;32(14):1743-51. doi: 10.1038/onc.2012.269. Epub 2012 Jul 2. Review.

PMID:
22751118
37.

Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendations.

Sanchez-Mazas A, Vidan-Jeras B, Nunes JM, Fischer G, Little AM, Bekmane U, Buhler S, Buus S, Claas FH, Dormoy A, Dubois V, Eglite E, Eliaou JF, Gonzalez-Galarza F, Grubic Z, Ivanova M, Lie B, Ligeiro D, Lokki ML, da Silva BM, Martorell J, Mendonça D, Middleton D, Voniatis DP, Papasteriades C, Poli F, Riccio ME, Vlachou MS, Sulcebe G, Tonks S, Nevessignsky MT, Vangenot C, van Walraven AM, Tiercy JM.

Int J Immunogenet. 2012 Dec;39(6):459-72; quiz 473-6. doi: 10.1111/j.1744-313X.2012.01113.x. Epub 2012 Apr 26.

38.

Asymptomatic bilateral pulmonary embolism in Churg-Strauss syndrome.

Maria A, Guilpain P, Forestier A, Delhom E, Schiffman A, Rivière S, Van Kien AK, Leray-Moragues H, Serre I, Vincent T, Eliaou JF, Le Quellec A.

Eur Respir Rev. 2012 Mar 1;21(123):75-7. doi: 10.1183/09059180.00007911. No abstract available.

39.

Evaluation of two automated capillary electrophoresis systems for human serum protein analysis.

Chartier C, Boularan AM, Dupuy AM, Badiou S, Bargnoux AS, Cognot C, Eliaou JF, Cristol JP.

Clin Biochem. 2011 Dec;44(17-18):1473-9. doi: 10.1016/j.clinbiochem.2011.05.022. Epub 2011 Jun 12.

PMID:
21664899
40.

Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay.

De Vidi I, Boursier G, Delouche N, Portalès P, Cadars E, Bouthier M, Mettling C, Lin YL, Thouvenot E, Carlander B, Camu W, Antel JP, Bar-Or A, Zephir H, Vermersch P, De Seze J, Corbeau P, Eliaou JF, Vincent T.

Clin Immunol. 2011 Mar;138(3):239-46. doi: 10.1016/j.clim.2010.11.012. Epub 2010 Dec 28.

PMID:
21190899
41.

Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont MC, Ranchin B, Fabien N, Cochat P, Pouteil-Noble C, Trolliet P, Durieu I, Tebib J, Kassai B, Ansieau S, Puisieux A, Eliaou JF, Bonnefoy-Bérard N.

Nat Immunol. 2009 Jul;10(7):778-85. doi: 10.1038/ni.1741. Epub 2009 May 31. Retraction in: Nat Immunol. 2014 Sep;15(9):894.

PMID:
19483719
42.

Molecular identity of skin and blood T-cell clones in cutaneous T-cell lymphoma patients as determined from the migration pattern of the T-cell receptor-gamma gene by capillary electrophoresis.

Gubler B, Marty-Grès S, Guillot B, Eliaou JF, Dereure O.

Electrophoresis. 2009 Mar;30(6):999-1007. doi: 10.1002/elps.200800198.

PMID:
19309017
43.

Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.

Mohty M, Avinens O, Faucher C, Viens P, Blaise D, Eliaou JF.

Haematologica. 2007 Jul;92(7):1004-6.

44.

Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations.

Spierings E, Hendriks M, Absi L, Canossi A, Chhaya S, Crowley J, Dolstra H, Eliaou JF, Ellis T, Enczmann J, Fasano ME, Gervais T, Gorodezky C, Kircher B, Laurin D, Leffell MS, Loiseau P, Malkki M, Markiewicz M, Martinetti M, Maruya E, Mehra N, Oguz F, Oudshoorn M, Pereira N, Rani R, Sergeant R, Thomson J, Tran TH, Turpeinen H, Yang KL, Zunec R, Carrington M, de Knijff P, Goulmy E.

PLoS Genet. 2007 Jun;3(6):e103.

45.

[Economic evaluation of the organization of a registry of haematopoietic stem cell donors].

Feve F, Cambon-Thomsen A, Eliaou JF, Gourraud PA, Raffoux C, Florens JP.

Rev Epidemiol Sante Publique. 2007 Aug;55(4):275-84. French.

PMID:
17597327
46.

IL-10 promoter and IL4-Ralpha gene SNPs are associated with immediate beta-lactam allergy in atopic women.

Guglielmi L, Fontaine C, Gougat C, Avinens O, Eliaou JF, Guglielmi P, Demoly P.

Allergy. 2006 Aug;61(8):921-7.

PMID:
16867043
47.

The presence of dominant T-cell clones in peripheral blood of patients with collagen vascular disorders: a prospective study of 97 cases.

Dereure O, Gubler B, Bessis D, Guillot B, Guilhou JJ, Clot J, Eliaou JF.

Br J Dermatol. 2006 Mar;154(3):445-9.

PMID:
16445773
48.

Influence of sex on disease severity in patients with rheumatoid arthritis.

Gossec L, Baro-Riba J, Bozonnat MC, Daurès JP, Sany J, Eliaou JF, Combe B.

J Rheumatol. 2005 Aug;32(8):1448-51.

PMID:
16078318
49.
50.

HLA-DMA*0103 and HLA-DMB*0104 alleles as novel prognostic factors in rheumatoid arthritis.

Morel J, Roch-Bras F, Molinari N, Sany J, Eliaou JF, Combe B.

Ann Rheum Dis. 2004 Dec;63(12):1581-6.

Supplemental Content

Loading ...
Support Center